News and Promotions
Chicago -- Nashville, Tenn., psychiatrist Andrew Michel, MD, often feels frustrated in his practice. He says his specialty's diagnostic system is not well-validated, that psychotropic medications are frequently ineffective, and that managed care means there is never enough time to plumb the depths of his patients' mental anguish.
Dr. Michel draws upon his Christian faith to find the will to sustain his commitment to medicine amid these challenges.
On a busy day, moving from one all-too-brief appointment to the next, he has time only for a simple prayer: "Lord, have mercy."
How medical practice and religious faith intersect was the subject of a Nov. 10 symposium hosted by the University of Chicago Program on Medicine and Religion. The event drew about 120 physicians, theologians, chaplains and clergy to hear lectures on topics such as "Judaism and the Practice of Medicine," "Christian Witness in Health Care" and "Medicine in an Apocalyptic Context."
The one-day event is just ...
Washington -- President Obama on Nov. 23 nominated Marilyn B. Tavenner to be the next administrator of the Centers for Medicare & Medicaid Services.
Donald M. Berwick, MD, the current CMS chief, will serve his last day on Dec. 2, according to a letter he sent to agency staff. He has been administrator since July 2010.
"Our work has been challenging, and the journey is not complete, but we are now well on our way to achieving a whole new level of security and quality for health care in America," Dr. Berwick wrote.
Dr. Berwick made a central goal at CMS his three-part aim of improving health care for individuals, improving population health and lowering health care costs. "He infused a deep commitment to patient-centered care into all the [CMS] innovations and was a tireless advocate for reforms that improve patient outcomes and patient experiences of care," said Debra L. Ness, president of the National Partnership for Women and Families, a health care advocacy organization.
Half of experts who write clinical practice guidelines for diabetes and high cholesterol have financial conflicts of interest with the drug industry, a study says.
One in nine panelists who said they had no conflicts actually had a conflict, said the study, published online Oct. 11 in the journal BMJ.
"Our main concern is that there is a potential risk of industry influence on developing guideline recommendations," said lead study author Jennifer Neuman, MD, an instructor of preventive medicine at Mount Sinai School of Medicine in New York. "For practitioners and developers alike, it's important to be mindful of this issue."
The study examined 14 guidelines published on diabetes and high cholesterol between 2000 and 2010 by national organizations in the United States and Canada. Those groups included the American Heart Assn. and the American Diabetes Assn. A financial conflict was defined as direct compensation to a guideline panelist by a manufacturer of a drug used to treat ...